The Science & Treatment of Obsessive Compulsive Disorder (OCD) | Huberman Lab Essentials

Mapping treatments to nodes of the corticostriatal–thalamic loop clarifies why some interventions work for some patients and guides which therapies to try or combine based on whether they target perception, action selection, or gating.

Laboratory studies find smoked cannabis produces no immediate improvement in OCD and gives smaller anxiety reductions than placebo, so cannabinoids do not acutely modulate the circuits driving obsessive-compulsive symptoms.

Clinical trials show CBT reduces OCD symptoms more than SSRIs and adding medication to CBT gives little extra benefit, implying CBT more effectively breaks the behavioral and circuit mechanisms that sustain symptoms.

Provoking symptom-specific stimuli during brain scans causes increased blood flow in the corticostriatal–thalamic loop, demonstrating the circuit becomes hyperactive exactly when obsessions and compulsions appear.

The thalamic reticular nucleus controls which sensory signals reach conscious awareness, and when that gating fails certain sensations or thoughts are more likely to reach awareness and become obsessive.

Myoinositol appears to lower baseline anxiety and improve sleep when taken at sufficient doses, which can indirectly boost the effectiveness of behavioral and pharmacologic OCD treatments.

Mindfulness primarily helps OCD by improving attention and homework adherence, which increases the effectiveness of exposure-based CBT rather than directly stopping obsessions.

Applying TMS to motor or supplementary motor areas interferes with automatic motor activation, so intrusive urges are less likely to translate into compulsive actions and symptoms drop.